Results 71 to 80 of about 37,713 (238)

Delphi Consensus Among French Obesity Experts on Clinical Recommendations for Drug Prescription in Patients With Severe Obesity

Obesity Reviews, EarlyView.
ABSTRACT Introduction Although the physiologic alterations seen in obesity often affect the pharmacokinetics and pharmacodynamics of drugs, most clinical trials do not consider these aspects specifically for this population. To date, there is no list of potentially inappropriate medications for patients living with obesity. The aim of this study was to
Sarah Berdot, Germain Perrin, Emmanuel Disse, Armelle Arnoux, Eric Bertin, Anne‐Laure Borel, Marie‐Claude Brindisi, Arnaud De Luca, Edouard‐Jules Laforgue, Jean‐Daniel Lalau, Yann Matussiere, Emilie Montastier, Agnès Sallé, Bérénice Segrestin, Valentine Suteau, French Hospital Expert Panel, Sebastien Czernichow, Brigitte Sabatier   +17 more
wiley   +1 more source

Potentiation of thiopental anaesthesia: wlith tigan®, panectyl®, benadryl®, gravol®, marzine®, histadyl®, librium®, and haloperidol (R 1625) [PDF]

, 1961
Allen B. Dobkin
openalex   +1 more source

The Genetic Blueprint of Obesity: From Pathogenesis to Novel Therapies

Obesity Reviews, EarlyView.
ABSTRACT Obesity is a chronic metabolic disease characterized by disturbances in energy homeostasis, leading to excessive fat accumulation. The pathogenesis of the disease is shaped by a complex interplay of genetic, epigenetic, biological, psychological, and environmental factors.
Gašper Tonin, Stjepan Eržen, Zala Mlinarič, Dubravka Jurišić Eržen, Simon Horvat, Tanja Kunej, Jasna Klen   +6 more
wiley   +1 more source

Haloperidol for Pain Management: A Narrative Review

Pharmaceuticals
The use of haloperidol in pain management has been a topic of interest for several decades. Haloperidol is a widely used antipsychotic medication with unique pharmacologic properties that make it a potential candidate for pain management.
Carlos J. Roldan, Jonathan W. Rowland, Alice L. Ye   +2 more
doaj   +1 more source

Quetiapine versus Haloperidol in Controlling Conversion Disorder Symptoms; a Randomized Clinical Trial

Emergency, 2017
Introduction: About 5% of visits to emergency departments are made up of conversion disorder cases. This study was designed with the aim of comparing the effectiveness of quetiapine and haloperidol in controlling conversion disorder symptoms.
Saeed Reza Ghanbarizadeh, Hossein Dinpanah, Reza Ghasemi, Yaser Salahshour, Samaneh Sardashti, Mostafa Kamali, Seyed Reza Khatibi   +6 more
doaj   +1 more source

Oral Adverse Effects of Antipsychotic Medications: A Case/Noncase Analysis of EudraVigilance Data

Oral Diseases, EarlyView.
ABSTRACT Objective Neuropsychiatric disorders are associated with poor oral health, with antipsychotics as potential contributors. This study aimed to analyse the oral adverse effects of antipsychotics using the EudraVigilance database. Methods A case/noncase analysis was conducted to calculate reporting odds ratios (ROR) and assess the ...
Leire Urien, Unax Lertxundi, Montserrat Garcia, Carmelo Aguirre, Nerea Jauregizar, Teresa Morera‐Herreras   +5 more
wiley   +1 more source

Acute transaminitis after initial days of starting haloperidol

Mental Illness, 2019
Haloperidol is a first-generation antipsychotic butyrophenone that is lipophilic, readily absorbed, and extensively metabolized in the liver. The occurrence of elevated liver enzymes with haloperidol is reported to be 2.4% with cases generally occurring ...
Rami Gabriel, Todd Wojtanowicz, Reza Farokhpay, Robert Bota   +3 more
doaj   +1 more source

CENTRAL EFFECTS OF HALOPERIDOL ON SOMATIC REFLEXES [PDF]

, 1965
Bhargava Kp, R. K. Srivastava
openalex   +1 more source

Rhabdomyolysis After Risperidone Overdose in a Patient With Schizophrenia: A Case Report

Neuropsychopharmacology Reports, Volume 45, Issue 3, September 2025.
ABSTRACT A 50‐year‐old woman with schizophrenia overdosed on risperidone, lormetazepam, and lorazepam and subsequently developed rhabdomyolysis, with elevated creatine kinase (CK) and myoglobin levels. Intravenous treatment stabilized her condition. Risperidone was restarted at a regular dose, and rhabdomyolysis did not recur.
Jun Takahashi, Kota Kikuchi, Rui Inano, Yasushi Kawamata, Norio Sugawara, Norio Yasui‐Furukori   +5 more
wiley   +1 more source

Clinical and Pharmacological Effects of Monoamine Precursors or Haloperidol in Chronic Schizophrenia [PDF]

, 1968
Torgny Persson, B. E. Roos
openalex   +1 more source